Trial intelligence / Profile preview

Dezocine vs sufentanil for emergence agitation and postoperative pain in pediatric oral comfort therapy

ChiCTR2400081284Phase 4Recruiting

Sponsor
Affiliated Stomatology Hospital of Anhui Medical University
Start
Feb 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dezocine in carious lesion (2 arms), sponsored by Affiliated Stomatology Hospital of Anhui Medical University. Primary endpoint: Emergence agitation. Started Feb 2024; status: recruiting.

02

Drugs

dezocine
03

Conditions

carious lesion

Beyond the preview

Go deeper on ChiCTR2400081284.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400081284.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call